| Meta-analysis summary statistics for associations meeting genome-wide significance | |||||||
|---|---|---|---|---|---|---|---|
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs1005390 | 4-acetamidobutanoate / X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide | T/G | 6520 | 0.8 | -0.035 (0.004) | 2.61·10-16 | show |
| rs1005390 | X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide | T/G | 7363 | 0.8 | 0.026 (0.003) | 2.5·10-14 | show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations | |
|---|---|
| SNP | rs1005390 |
| Chromosomal location | Chr7: 150,174,654 (7q36.1) |
| Gene (distance) | ABP1 (-5,851) |
| Predicted causal gene | ABP1 (AOC1) |
| Gene/protein classification | metabolic enzyme |
| Metabolite (Pathway) | 4-acetamidobutanoate (Guanidino and acetamido metabolism; Amino acid) X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (Polyamine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | ABP1 (now called AOC1) encodes a copper containing amide oxidase which can deaminate N1-acetylspermidine to produce N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). X-03056 has been annotated as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). Ratio interepretation: 'selectivity'. |
| eQTL associations | KCNH2 (L), REPIN1 (L), TMEM176A (F) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information | |
|---|---|
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information | |
|---|---|
| ChEMBL ID | CHEMBL2118 |
| Drug information | No specific drug is primarily metabolised by this enzyme; compounds with inhibitory activity in ChEMBL |
| Locus information for top associated metabolite | |
|---|---|
HapMap2 imputation![]() | 1KGP imputation![]() |








